FIELD: biotechnologies.
SUBSTANCE: invention refers to conjugate of gossypol with sodium-carboxymethyl cellulose with molecular mass of 780-180000 Da at the ratio of gossypol to sodium-carboxymethyl cellulose of (1-5):(99-95) wt % and content of low-molecular fraction with molecular mass of 780 to 1500 Da of up to 20% and high-molecular fraction with molecular mass of 1500 to 180000 Da of up to 80%, conjugate of gossypol with sodium-carboxymethyl cellulose with molecular mass of 780 to 1500 Da at the ratio of gossypol to sodium-carboxymethyl cellulose of (0.35-1.76):(99.65-98.24) wt %, and conjugate of gossypol with sodium-carboxymethyl cellulose with molecular mass of 1500 to 180000 Da at the ratio of gossypol to sodium-carboxymethyl cellulose of (0.65-3.23):(99.35-96.77) wt %, and their production methods. Besides, the invention refers to antiviral agents on the basis of the above conjugates and pharmaceutical compositions containing conjugates.
EFFECT: improving compound application efficiency.
21 cl, 5 tbl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
GOSSYPOL POLYMER DERIVATIVES, METHODS FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION BASED THEREON | 2014 |
|
RU2577539C2 |
ANTIMICROBIAL COMPOSITION BASED ON POLYPHENOLS AND POLYSACCHARIDES, METHOD FOR ITS PREPARATION AND APPLICATION | 2018 |
|
RU2754067C2 |
ANTI-INFECTIOUS PHARMACEUTICAL PREPARATION | 2003 |
|
RU2238122C1 |
METHOD OF PRODUCING COPOLYMER OF SODIUM CARBOXY-METHYLCELLULOSE AND GOSSYPOL AND USE THEREOF IN COMPLEX THERAPY OF PATIENTS WITH AUTISTIC DISORDERS AND COGNITIVE IMPAIRMENTS | 2010 |
|
RU2453559C1 |
CARBOXYMETHYLCELLULOSE COPOLYMER AND GOSSYPOL SODIUM SALT, PHARMACEUTICAL COMPOSITION AND METHOD FOR PROPHYLAXIS OR TREATMENT OF VIRAL DISEASE | 2004 |
|
RU2270708C1 |
ASYMMETRIC DERIVATIVES OF DINAPHTHALENE POLYPHENOLS, THEIR PRODUCTION METHOD AND APPLICATION | 2017 |
|
RU2766222C2 |
NOVEL FUNCTIONALLY ACTIVE, HIGHLY PURE, STABLE CONJUGATE OF INTERFERON α WITH POLYETHYLENE GLYCOL, REPRESENTED BY ONE PEG- NH-IFN POSITIONAL ISOMER, WITH IMPROVED IMMUNOGENICITY, WITH PROLONGED BIOLOGICAL ACTION, SUITABLE FOR MEDICAL APPLICATION, AND IMMUNOLOGICAL AGENT BASED THEREON | 2010 |
|
RU2447083C1 |
APPLICATION OF CELLULOSE DERIVATIVE AND GOSSYPOL AQUEOUS SOLUTION AS RADIOPROTECTOR, ANTI-INFECTIVE, AND POTENTIATING AGENT, METHOD FOR PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION BASED THEREON | 2000 |
|
RU2222548C2 |
MULTIMODAL POLYMER COMPOSITION FOR TUBES AND TUBES MANUFACTURING THEREFROM | 1999 |
|
RU2223987C2 |
A CONJUGATE OF HYDROXYALKYL STARCH AND LOW-MOLECULAR SUBSTANCE AND METHOD OF OBTAINING IT | 2003 |
|
RU2327702C2 |
Authors
Dates
2013-11-20—Published
2012-06-14—Filed